Hot Lots - Viral Vaccine Paper - AKA “The Danish Paper”.
Dr. Campbell and Co-author Dr. Manniche discuss a research paper from Denmark that demonstrated early batches of COVID19 “vaccines” were associated with very high levels of adverse events.
Dr. Manniche’s article can be found here: https://onlinelibrary.wiley.com/doi/10.1111/eci.13998
Time series analysis of US government data raises similar issues.
The graph below is a plot of a recent download from the CDC of monthly number of doses administered in orange and the number of adverse event reports by month of injection in VAERS (vaccine adverse event reporting system maintained by the CDC/FDA). The primary axis on the left is for doses administered and ranges from under 10 million in December of 2020 to over 90 million at the dosing peak in April of 2021. Adverse events begin at 24,421 in December of 2020 and peak in March-April with over 120,000 adverse event reports per month.
The slope of the blue line is steeper than the orange showing a rate of rise greater for adverse event reports than the rate of dosing until February 2021 when there was a data anomaly. Albert Benavides has referred to this type of anomaly as “throttling”.
There is close fitting of the two curves until October of 2021 when the curves diverge sharply for each of three subsequent dosing peaks.
The reduced (only a small increase in slope) rate of adverse event reports in the secondary, tertiary and quaternary dosing periods compared with the first suggests another type of intervention. Possibilities include a change in the formulation of the mRNA products discussed by Dr. Manniche or data manipulation, or something else.
This plot is consistent with the data discussed by Dr. Manniche through two cycles. Additional analysis of data is required for cycles three and four.
During the period from December 2020 through February of 2021 Pfizer collected adverse events reports from over 40,000 people (Pfizer Confidential Document 5.3.6). This data was gathered during the time of the VAERS data anomaly in January to March of 2021. Pfizer and hired an additional 2,400 employees to handle the volume.